Tocilizumab for reduction of mortality in severe COVID-19 patients: How should we GRADE it?

중증 COVID-19 환자의 사망률 감소를 위한 Tocilizumab: 어떻게 등급을 매겨야 합니까?

Published on 2022-07-012022-09-12
Journal: British Journal of Clinical Pharmacology

[키워드] Abstract COVID-19 Evidence GRADE Mortality reduction severe COVID-19 Tocilizumab

[저자] Vladimir Trkulja

[Category] COVID19(2023년), SARS, 진단,

PMC URL [DOI] 10.1111/bcp.15283

[Article Type] Article

[Source] PMC

No abstract available
Keywords: COVID-19; GRADE; evidence; tocilizumab.

All Keywords
【저자키워드】 COVID-19, Tocilizumab, Evidence, GRADE, 【초록키워드】 Tocilizumab, Abstract, 【제목키워드】 Mortality, severe COVID-19, reduction,

사용 가능한 초록 없음 {{ 키워드: }} 코로나19; 등급; 증거; 토실리주맙.